Article Details

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - BNN Bloomberg

Retrieved on: 2024-11-17 23:11:02

Tags for this article:

Click the tags to see associated articles and topics

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - BNN Bloomberg. View article details on hiswai:

Excerpt

Halozyme Therapeutics Inc. plans to finance its €2 billion ($2.1 billion) proposed takeover of Germany's Evotec SE in cash, according to Chief ...

Article found on: www.bnnbloomberg.ca

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo